Cargando…
Targeting Disseminated Estrogen-Receptor-Positive Breast Cancer Cells in Bone Marrow
Estrogen receptor-positive (ER+) breast cancer can recur up to 20 years after initial diagnosis. Delayed recurrences arise from disseminated tumors cells (DTCs) in sites such as bone marrow that remain quiescent during endocrine therapy and subsequently proliferate to produce clinically-detectable m...
Autores principales: | Buschhaus, Johanna M., Humphries, Brock A., Eckley, Samantha S., Robison, Tanner H., Cutter, Alyssa C., Rajendran, Shrila, Haley, Henry R., Bevoor, Avinash S., Luker, Kathryn E., Luker, Gary D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442734/ https://www.ncbi.nlm.nih.gov/pubmed/32678295 http://dx.doi.org/10.1038/s41388-020-01391-z |
Ejemplares similares
-
Enhanced mitochondrial fission inhibits triple-negative breast cancer cell migration through an ROS-dependent mechanism
por: Humphries, Brock A., et al.
Publicado: (2023) -
Short-Term Environmental Conditioning Enhances Tumorigenic Potential of Triple-Negative Breast Cancer Cells
por: Eckley, Samantha S., et al.
Publicado: (2019) -
A Caspase-3 Reporter for Fluorescence Lifetime Imaging of Single-Cell Apoptosis
por: Buschhaus, Johanna M., et al.
Publicado: (2018) -
Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer
por: Humphries, Brock A., et al.
Publicado: (2020) -
Multiparametric MRI to quantify disease and treatment response in mice with myeloproliferative neoplasms
por: Robison, Tanner H., et al.
Publicado: (2022)